# Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin

> **NCT03424408** · NA · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 20 (actual)

## Conditions studied

- Aspirin

## Interventions

- **DRUG:** Aspirin 81 mg

## Key facts

- **NCT ID:** NCT03424408
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-09-03
- **Final completion:** 2019-09-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424408, "Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03424408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*